↓ Skip to main content

Dove Medical Press

Profile of palbociclib in the treatment of metastatic breast cancer

Overview of attention for article published in Breast cancer targets and therapy, May 2016
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

patent
7 patents

Citations

dimensions_citation
16 Dimensions

Readers on

mendeley
98 Mendeley
Title
Profile of palbociclib in the treatment of metastatic breast cancer
Published in
Breast cancer targets and therapy, May 2016
DOI 10.2147/bctt.s83146
Pubmed ID
Authors

Moataz Ehab, Mohamad Elbaz

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 98 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Unknown 97 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 19 19%
Researcher 12 12%
Student > Bachelor 11 11%
Other 8 8%
Student > Master 8 8%
Other 17 17%
Unknown 23 23%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 23 23%
Medicine and Dentistry 18 18%
Agricultural and Biological Sciences 11 11%
Pharmacology, Toxicology and Pharmaceutical Science 10 10%
Chemistry 5 5%
Other 5 5%
Unknown 26 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 October 2023.
All research outputs
#8,535,684
of 25,374,917 outputs
Outputs from Breast cancer targets and therapy
#117
of 324 outputs
Outputs of similar age
#113,918
of 311,862 outputs
Outputs of similar age from Breast cancer targets and therapy
#4
of 7 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 324 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.0. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 311,862 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.